Amneal reports fourth quarter and full year 2020 financial results

Bridgewater, n.j.--(business wire)--amneal pharmaceuticals, inc. (nyse: amrx) (the "company") announced its results today for the fourth quarter and full year ended december 31, 2020. "we are extremely proud of the progress our company has made since we re-joined as leaders of amneal," said chirag and chintu patel, co-chief executive officers. "in just a year and a half, we have made significant strides towards strategically positioning amneal, both operationally and financially, for the next p
AMRX Ratings Summary
AMRX Quant Ranking